Aegis Peptide Analytics was founded on a single premise: the peptide research and supply industry needed a genuinely independent testing laboratory — one with no affiliations, no conflicts of interest, and no incentive to produce any result other than the true one.
Our Mission
“To provide the peptide research community with independent, scientifically rigorous testing that makes fraud difficult, accountability real, and trust possible.”
— Aegis Peptide Analytics founding charter, 2026
Every analytical laboratory faces a fundamental question: who does the data serve? At most labs, the answer is the client who paid. At Aegis, the answer is the truth.
We enforce our independence through structural means — not just policy. We do not accept equity, commissions, referral fees, or any form of compensation from any entity in the peptide supply chain. Our revenue is testing fees only.
Our conflict-of-interest policy is published publicly. Any violation by any staff member is grounds for immediate termination. This is not a soft commitment — it is the precondition for everything we do.
Quality management documentation under active development for third-party accreditation audit submission.
All analytical methods validated and operated per current USP general chapters.
Method validation protocols conform to ICH Q2(R1) guidance for accuracy, precision, linearity, and limits.
Our leadership combines deep pharmaceutical analytical expertise with a shared commitment to data integrity and transparent science.
Laboratory Director
Analytical Chemistry, UC San Diego (2018)
12+ years in pharmaceutical analytical testing. Former senior analyst at a contract research organization. Expert in HPLC method development and LC-MS/MS validation per ICH Q2(R1).
Senior Analytical Scientist
Biochemistry, University of Michigan (2019)
Specializes in peptide characterization, mass spectrometry, and USP <232>/<233> elemental impurity testing. Published in Journal of Pharmaceutical Analysis.
Quality Assurance Lead
M.S. Regulatory Science, USC
Oversees SOP compliance, chain of custody documentation, and client report accuracy. Former QA specialist at a California-licensed clinical testing lab.
Irvine Research Campus
1247 Research Parkway, Suite 400
Irvine, CA 92612
Intake Method
Mail-in sample submission
Lab Type
Independent analytical laboratory
Primary Instruments
HPLC-UV · LC-MS/MS · GC-FID · ICP-MS
Quality System
ISO/IEC 17025 in preparation
These are not aspirations — they are operational commitments enforced through systems, policy, and public accountability.
We test for anyone. We work for no one. Aegis has zero financial relationships with any peptide supplier, manufacturer, retailer, or broker. Our only revenue comes from testing fees. Full stop.
Every COA we issue is write-once. We have architected our systems so that results cannot be retroactively modified after certificate issuance. We publish this guarantee in our terms.
We document everything. Every COA includes the exact instrument, method, reference standard, and calibration data used. No black boxes. No proprietary secrets. Full methodology visible.
We built efficient workflows that deliver 48–72 hour turnaround without cutting analytical corners. Our clients shouldn't have to choose between speed and accuracy.
Our public verification portal exists because we believe all COA data should be verifiable by anyone — buyers, regulators, and the public — not just the entity that paid for the test.
All methods are validated against USP, ICH, and FDA analytical guidelines. We use certified reference standards, calibrated instruments, and documented procedures for every single test.
Our laboratory is staffed by PhD-level analytical chemists and pharmaceutical QC specialists with combined decades of experience in validated method development, regulatory submissions, and high-throughput analytical workflows.
Staff names are not publicly listed as a standard security practice for analytical laboratories handling research compounds.
Ph.D. · Analytical Chemistry
Pharmaceutical QC · 12+ years
Method validation authority, COA final sign-off, quality system oversight, and ISO 17025 compliance program.
M.S. · Pharmaceutical Sciences
USP Reference Laboratory · 8+ years
HPLC-UV purity analysis, system suitability execution, chromatographic method development and troubleshooting.
Ph.D. · Biochemistry
Peptide/proteomics specialization · 10+ years
LC-MS/MS identity confirmation, molecular fragmentation interpretation, and complex peptide characterization.
B.S. · Chemistry · GMP certification
Pharmaceutical manufacturing QC · 9+ years
Data integrity review, SOP compliance, second-analyst data verification, and chain of custody documentation.
Validated Methods
Independent Testing
Avg Turnaround
Contested Results
Whether you're a researcher verifying a single batch or a manufacturer building a compliance program, we have a panel that fits.